This week, we had the pleasure of hosting Prof. Ian Fairlamb from the University of York, as part of the Invited Speaker Programme. Prof. Fairlamb discussed how to improve outcomes of palladium-catalysed reactions for discovery and process chemistry. We thank Prof. Fairlamb for his visit! Learn more about Pharmaron’s process chemistry services: https://buff.ly/3UCRUjo #processchemistry #drugdiscovery #chemistry #drugdevelopment #pharmaron
关于我们
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * Synthetic, medicinal and analytical chemistry services * Biology services * DMPK services * Pharmacology services * Drug safety assessment services * Radiochemistry and isotopically labelled metabolism services * Chemical & pharmaceutical development services * Clinical development services www.pharmaron.com CRO - Contract Research Organization & CDMO - Contract Development Manufacturing Organization Library Synthesis CADD Bioorganic Chemistry Discovery Process Chemistry Radiolabelled Chemical Synthesis ChemInformatics in vitro Biology in vitro Screening Structural Biology in vivo Pharmacology Animal Disease Models ex vivo Pharmacology Biomarkers in vitro ADME in vivo PK PKPD QA Regulatory Affairs Discovery Biologics Process Chemistry API Manufacturing Material Science Formulation Development Drug Product Manufacturing Toxicology Safety Pharmacology Genetic Toxicology DART Pathology Immunotoxicity Bioanalytical 14C / Carbon-14 Radiosynthesis 3H / Tritium Radiosynthesis QWBA mARG Clinical AME Mass Balance Metabolite Profiling Microdosing Phase 0 Absolute Bioavailability DDI First-in-Human (FIH) Thorough QT(TQT) Ethnobridging
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Beijing
- 类型
- 私人持股
- 领域
- Chemistry、Biology、DMPK、Pharmacology、Chemical Development、Preclinical、Toxicology、Safety Pharmacology、Discovery、Lead Optimization、Process Development、Assay Development、ADME、Formulation、clinical pharmacology、analytical sciences、radiolabelled chemistry、accelerator mass spectrometry、radiolabelled compounds、API manufacturing、radiosynthesis、Biologics和CTG Products
地点
Pharmaron员工
动态
-
Join us for our next virtual chemistry lecture on Thursday, July 4, 2024, at 9:15 am (China Standard Time). 𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗣𝘆𝗿𝗶𝗱𝗶𝗻𝗲𝘀, 𝗗𝗶𝗮𝘇𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝘃𝗶𝗮 𝗨𝗻𝗰𝗼𝗻𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘁𝗲𝗿𝗺𝗲𝗱𝗶𝗮𝘁𝗲𝘀 Prof. Andy McNally Department of Chemistry Colorado State University Register for the webinar: https://lnkd.in/dKdJXAdc Pyridines and diazines are ubiquitous in pharmaceuticals and agrochemicals, yet there are limits in synthetic methods that can directly functionalize the C–H bonds in these structures. In this lecture, Prof. Andy McNally will show two distinct approaches, using phosphorus and ring-opened intermediates, that enable selective functionalization of these heterocycles into a range of valuable derivatives. A range of C–C and C–Heteroatom bond formations are viable, and the chemistry functions on structures typically encountered in drug discovery programs. Prof. McNally's lab has also performed mechanistic and computational studies of the regioselectivity of these reactions and the phosphorus ligand-coupling processes involved.
-
-
Pharmaron转发了
Discover Pharmaron's Advanced AAV Gene Therapy Platform! At Pharmaron, we have developed a robust platform process for creating AAV gene therapies, equipped with a highly adaptive toolbox to manage various AAV products and serotypes. Our innovative toolbox allows us to rapidly assess a product’s compatibility with our platform and finely tune multiple parameters for optimal results. Learn more by downloading our poster: Utilising HTPD and DoE to Optimise the Pharmaron Gene Therapy Platform: https://lnkd.in/e9w2Xj7c #GeneTherapy #AAV #Biotechnology #Pharmaron #HTPD #DoE #Innovation
-
Explore Pharmaron's 5-star in vivo oncology services ⭐️⭐️⭐️⭐️⭐️ Learn more about our in vivo oncology and immunooncology capabilities here: https://lnkd.in/d3ydtmCT #oncology, #drugdiscovery, #tumormodels #cancerresearch
-
-
Pharmaron uses cell painting with subsequent data analysis with machine learning for a variety of applications to make this sensitive and powerful method available to our clients. Cell painting enables: •Phenotypic drug discovery •Target deconvolution •Analysis of signaling pathways and mechanism of action •Investigating drug resistance mechanisms The cells are screened via the high content imaging system Operetta and comprehensive data analysis is conducted by our adept bioinformaticians utilizing machine learning algorithms. Our fully automated, high-throughput assay and screening process is finely tuned to expedite cell painting applications with precision. To learn more about this fascinating technique and how we can support your drug discovery projects, please visit our website for more details and a case study showing a profiling study with 390 kinase inhibitors: https://lnkd.in/eg5vi7UB #pharmaron #drugdiscovery #cellpainting #machinelearning #highthroughputscreening #bioinformatics #morphologicalprofiling
-
-
As the final day of BOS Basel 2024 wraps up, we want to thank everyone for the great connections and insightful discussions we've had here in Switzerland. It has been a fantastic experience meeting industry experts and sharing our comprehensive drug substance and drug product services. Thank you to everyone who visited us at booth #36. We look forward to continuing these conversations and exploring new opportunities for collaboration. #BOSBasel #Pharmaron #LifeScience #CMC #Biologics #Radiolabelled
-
-
We're off to a great start at BOS Basel 2024 in Switzerland! It’s been great connecting with industry experts, and our team looks forward to meeting you tomorrow for Day 2. Stop by booth #36 to learn more about Pharmaron's fully integrated drug substance and drug product services. #Pharmaron #CDMO #BOSBasel #drugsubstance #drugproduct
-
Join us on June 21 for an exclusive event in Stevenage focusing on Modulating RNA with Oligonucleotides or Small Molecules. Connect with our team of experts, Filipa Antunes, Innocent Mushi, and Natalie Windle, to explore how Pharmaron can enhance your current and upcoming projects. Schedule a meeting with the team: https://lnkd.in/drrcNF4H Interested in Oligo? Register for Pharmaron's upcoming webinar on Oligonucleotide Drugs: https://buff.ly/3X1DzyI #Pharmaron #LifeScience #RNA #Oligo
-
-
We're excited to meet you at BOS Basel on June 19-20 in Switzerland! Visit us at stand #36 to discover our comprehensive drug substance and drug product services. Our expert team—Kassim Kolia, Héloïse Beutier, Ajiroghene Thomas, and Florian Schwaak—will be there to discuss how we can support your current and future projects. #BOSBasel #Pharmaron #LifeScience #CMC #Biologics #Radiolabelled
-
-
Had an amazing time at the 2024 NE ADME Conference in Boston! A big thank you to The Boston Society for organizing this fantastic event. Our team enjoyed connecting with industry leaders and sharing valuable insights. If you missed us at the conference or couldn’t attend, we'd love to continue the conversation. Learn more about how our innovative approaches can support your projects by scheduling a meeting with our team, here: https://lnkd.in/euGs52Hk #NEADME #Conference #Boston #DrugDiscovery #DMPK #Bioanalysis #RLS #Pharmaron #LifeScience
-